debate: ibd patient on biologic or immunomodulator who develops a malignancy - may continue meds
Published 10 years ago • 495 plays • Length 19:03Download video MP4
Download video MP3
Similar videos
-
11:32
debate: ibd patient on biologic or immunomodulator who develops a malignancy - must stop these meds
-
21:04
risks of malignancies due to ibd and immunomodulators and/or biologic therapy
-
29:01
case discussion ii: the biologically-experienced ibd patient
-
21:14
when and how to use immunomodulators and biologics in ibd
-
17:18
debate: asymptomatic uc patient on an immunomodulator with mucosal inflammation - no biologics
-
27:32
ibd surgery debate 2: crohn's colitis
-
18:22
other major side effects due to immunomodulators and/or biologics in our ibd patients
-
18:03
understanding the contraindications to the use of immunomodulators and biologics for ibd
-
1:12:17
non-tuberculous mycobacteria, part 1 -- anthony cannella, md
-
56:31
the food factor in ibd: what gastroenterologists & their patients should consider...
-
9:06
inflammatory bowel disease - ulcerative colitis v crohn's disease (with histology & manifestations)
-
32:29
keynote speaker: understanding the monitoring and safety of ibd medications and biologics
-
27:13
ibd management in the face of malignancy
-
2:36
biologic or biosimilar in ibd. it doesn’t matter which.
-
10:22
debate: asymptomatic uc patient on an immunomodulator with mucosal inflammation - add biologics
-
23:44
mechanisms of disease: biologic pipeline for ibd
-
18:02
perspectives on immunomodulators and biologics: risk of neoplasia and malignancy development
-
20:56
managing ibd in the elderly
-
8:01
debate: a patient with severe crohn's with stricture and proximal dilation should have medical ther
-
19:37
how often do immunomodulators and/or biologics cause lymphoma and/or cancer, and can we prevent it?
-
21:30
ibd: beyond combination therapy
-
18:43
neurologic, rheumatologic, and optic complications related to immunomodulators and biologic